PE20160882A1 - Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal - Google Patents
Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinalInfo
- Publication number
- PE20160882A1 PE20160882A1 PE2016000430A PE2016000430A PE20160882A1 PE 20160882 A1 PE20160882 A1 PE 20160882A1 PE 2016000430 A PE2016000430 A PE 2016000430A PE 2016000430 A PE2016000430 A PE 2016000430A PE 20160882 A1 PE20160882 A1 PE 20160882A1
- Authority
- PE
- Peru
- Prior art keywords
- bowel syndrome
- irritable bowel
- antibodies
- diagnosis
- treatment
- Prior art date
Links
- 208000002551 irritable bowel syndrome Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 208000028774 intestinal disease Diseases 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Ecology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361888658P | 2013-10-09 | 2013-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160882A1 true PE20160882A1 (es) | 2016-09-14 |
Family
ID=52813648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2016000430A PE20160882A1 (es) | 2013-10-09 | 2014-10-09 | Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US9851361B2 (enExample) |
| EP (1) | EP3054977B1 (enExample) |
| JP (1) | JP6567509B2 (enExample) |
| KR (1) | KR102259588B1 (enExample) |
| CN (1) | CN105744956B (enExample) |
| AU (2) | AU2014331841B2 (enExample) |
| BR (1) | BR112016007474A2 (enExample) |
| CA (1) | CA2923651C (enExample) |
| CL (1) | CL2016000820A1 (enExample) |
| ES (1) | ES2892905T3 (enExample) |
| IL (1) | IL244971B2 (enExample) |
| MX (1) | MX383423B (enExample) |
| NZ (1) | NZ717633A (enExample) |
| PE (1) | PE20160882A1 (enExample) |
| PL (1) | PL3054977T3 (enExample) |
| PT (1) | PT3054977T (enExample) |
| RU (1) | RU2683781C2 (enExample) |
| SG (1) | SG11201601733VA (enExample) |
| WO (1) | WO2015054529A1 (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9851361B2 (en) | 2013-10-09 | 2017-12-26 | Cedars-Sinai Medical Center | Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome |
| US9952223B2 (en) | 2012-09-17 | 2018-04-24 | Cedars-Sinai Medical Center | Method for detecting anti-vinculin antibodies in a subject with an IBS symptom |
| US10132814B2 (en) | 2014-10-09 | 2018-11-20 | Cedars-Sinai Medical Center | Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
| US10151752B2 (en) | 2009-02-11 | 2018-12-11 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
| US12222352B2 (en) | 2017-01-30 | 2025-02-11 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
| CN105784989A (zh) * | 2016-05-17 | 2016-07-20 | 上海凯璟生物科技有限公司 | 一种肠易激综合症标志物CdtB抗体检测试剂盒及其制备方法 |
| CN106053827A (zh) * | 2016-05-17 | 2016-10-26 | 上海凯璟生物科技有限公司 | 一种肠易激综合症标志物Vinculin抗体检测试剂盒及其制备方法 |
| KR20240095363A (ko) * | 2016-05-20 | 2024-06-25 | 세다르스-신나이 메디칼 센터 | 유전자에 기반한 염증성 장 질환의 진단 |
| RU2763258C1 (ru) * | 2020-07-13 | 2021-12-28 | Евгения Николаевна Воронина | Способ дифференциальной диагностики воспалительных заболеваний кишечника у детей по комплексу клинико-анамнестических, лабораторных и инструментальных критериев |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691151A (en) * | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| FR2806805A1 (fr) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
| WO2003097854A2 (en) | 2002-05-17 | 2003-11-27 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| EP1578364A4 (en) | 2002-09-16 | 2011-06-08 | Genentech Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM |
| US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
| US20050004155A1 (en) * | 2003-04-08 | 2005-01-06 | Boyd Thomas A. | Use of methylnaltrexone to treat irritable bowel syndrome |
| JP4711963B2 (ja) * | 2003-09-15 | 2011-06-29 | オクラホマ メディカル リサーチ ファウンデーション | 炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法 |
| CN102634524B (zh) | 2003-12-05 | 2014-03-05 | 扶桑药品工业株式会社 | 细胞致死肿胀毒素及以其为目标的弯曲杆菌属细菌的检测 |
| WO2008140484A2 (en) | 2006-11-09 | 2008-11-20 | Xdx, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| DK2223121T3 (da) | 2007-12-20 | 2012-10-22 | Index Diagnostics Ab Publ | Fremgangsmåde og kit til anvendelse ved differentiering mellem ibd og ibs og yderligere skelnen mellem ibd-sygdomstyper |
| EP2370435B1 (en) | 2008-11-24 | 2015-01-07 | Cedars-Sinai Medical Center | Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
| BRPI1008058A8 (pt) | 2009-02-11 | 2018-03-27 | Cedars Sinai Medical Center | uso de antibióticos para reduzir a probabilidade de desenvolver síndrome do intestino irritável pós-infecciosa |
| MX383424B (es) * | 2009-02-11 | 2025-03-14 | Cedars Sinai Medical Center | Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni |
| FR2942541A1 (fr) | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une vascularite |
| RU2397178C1 (ru) * | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса |
| IT1400989B1 (it) | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
| GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| KR102203568B1 (ko) | 2012-09-17 | 2021-01-15 | 세다르스-신나이 메디칼 센터 | 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료 |
| AU2014331841B2 (en) | 2013-10-09 | 2020-03-12 | Cedars-Sinai Medical Center | Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease |
| ES3028294T3 (en) | 2014-10-09 | 2025-06-18 | Cedars Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
| CN106091069A (zh) | 2016-06-15 | 2016-11-09 | 安徽省绿巨人环境技术有限公司 | 一种废水再利用装置 |
| EP3573650A4 (en) | 2017-01-30 | 2020-12-09 | Cedars-Sinai Medical Center | DIAGNOSIS OF SCLERODERMIA |
-
2014
- 2014-10-09 AU AU2014331841A patent/AU2014331841B2/en active Active
- 2014-10-09 WO PCT/US2014/059957 patent/WO2015054529A1/en not_active Ceased
- 2014-10-09 US US15/021,850 patent/US9851361B2/en active Active
- 2014-10-09 BR BR112016007474A patent/BR112016007474A2/pt not_active Application Discontinuation
- 2014-10-09 SG SG11201601733VA patent/SG11201601733VA/en unknown
- 2014-10-09 KR KR1020167011774A patent/KR102259588B1/ko active Active
- 2014-10-09 CA CA2923651A patent/CA2923651C/en active Active
- 2014-10-09 IL IL244971A patent/IL244971B2/en unknown
- 2014-10-09 NZ NZ717633A patent/NZ717633A/en unknown
- 2014-10-09 JP JP2016521777A patent/JP6567509B2/ja active Active
- 2014-10-09 MX MX2016004167A patent/MX383423B/es unknown
- 2014-10-09 PL PL14851688T patent/PL3054977T3/pl unknown
- 2014-10-09 RU RU2016116766A patent/RU2683781C2/ru active
- 2014-10-09 PT PT14851688T patent/PT3054977T/pt unknown
- 2014-10-09 PE PE2016000430A patent/PE20160882A1/es unknown
- 2014-10-09 EP EP14851688.3A patent/EP3054977B1/en active Active
- 2014-10-09 CN CN201480055994.5A patent/CN105744956B/zh active Active
- 2014-10-09 ES ES14851688T patent/ES2892905T3/es active Active
-
2016
- 2016-04-08 CL CL2016000820A patent/CL2016000820A1/es unknown
-
2017
- 2017-12-12 US US15/839,366 patent/US10352944B2/en active Active
-
2020
- 2020-05-27 AU AU2020203468A patent/AU2020203468A1/en not_active Abandoned
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10151752B2 (en) | 2009-02-11 | 2018-12-11 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
| US10527621B2 (en) | 2009-02-11 | 2020-01-07 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
| US9952223B2 (en) | 2012-09-17 | 2018-04-24 | Cedars-Sinai Medical Center | Method for detecting anti-vinculin antibodies in a subject with an IBS symptom |
| US9851361B2 (en) | 2013-10-09 | 2017-12-26 | Cedars-Sinai Medical Center | Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome |
| US10352944B2 (en) | 2013-10-09 | 2019-07-16 | Cedars-Sinai Medical Center | Method of determinig levels of anti-vinculin and anti-cytolethal distending toxin antibodies in subjects desiring to distinguish irritable bowel syndrome from inflammatory bowel disease |
| US10132814B2 (en) | 2014-10-09 | 2018-11-20 | Cedars-Sinai Medical Center | Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
| US12222352B2 (en) | 2017-01-30 | 2025-02-11 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160882A1 (es) | Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal | |
| MX387936B (es) | Metodo para la cuantificacion de huevos de parasitos en las heces. | |
| BR112016019836A2 (pt) | método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito | |
| BR112015026242A2 (pt) | dispositivo de coleta de fluido biológico e sistema de separação e testagem de fluido biológico | |
| MX2018002400A (es) | Receptores de antigenos quimericos condicionalmente activos para celulas t modificadas. | |
| HK1223361A1 (zh) | 用於预测肠易激综合征诊断的途径特异性测定 | |
| MX374652B (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. | |
| MX355020B (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| EA201792497A1 (ru) | Антитела к gitr для диагностики злокачественной опухоли | |
| BR112015019614A8 (pt) | análise de imagens e medições de amostras biológicas | |
| BR112015022490A2 (pt) | métodos e composições para classificação de amostras | |
| MX2016013255A (es) | Metodos y composiciones para detectar proteinas mal plegadas. | |
| MX2016002537A (es) | Anticuerpos y ensayos para la detección del receptor 1 de folato. | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| WO2016198833A3 (en) | Methods for analysing a urine sample | |
| BR112016016101A2 (pt) | Métodos para determinar o estado do distúrbio inflamatório, para monitorar a progressão de uma doença inflamatória ou monitorar a eficácia de um tratamento, kit, e, uso da determinação da presença, ou do nível, de tesnacina-c citrulinada e/ou um ou mais fragmentos de tesnacina-c citrulinada e/ou de autoanticorpos com especificidade para os mesmos | |
| BR112015004800A2 (pt) | método e aparelho para examinar ovos | |
| MX2017014196A (es) | Deteccion de factores de virulencia microbiana bucal. | |
| MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
| TR201903974T4 (tr) | Tasnif makinesi için otomatik kusur tanı metodu ve cihazı. | |
| MX384921B (es) | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. | |
| MX2017000840A (es) | Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer. | |
| MX2021012347A (es) | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. | |
| EA201790696A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности | |
| EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов |